- Home
- ISD vs TMCI Comparison
ISD vs TMCI Comparison
Compare ISD & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISD
- TMCI
- Stock Information
- Founded
- ISD 2012
- TMCI 2014
- Country
- ISD United States
- TMCI United States
- Employees
- ISD N/A
- TMCI N/A
- Industry
- ISD Trusts Except Educational Religious and Charitable
- TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ISD Finance
- TMCI Health Care
- Exchange
- ISD Nasdaq
- TMCI Nasdaq
- Market Cap
- ISD 472.3M
- TMCI 449.2M
- IPO Year
- ISD N/A
- TMCI 2021
- Fundamental
- Price
- ISD $14.63
- TMCI $7.22
- Analyst Decision
- ISD
- TMCI Hold
- Analyst Count
- ISD 0
- TMCI 5
- Target Price
- ISD N/A
- TMCI $8.60
- AVG Volume (30 Days)
- ISD 127.1K
- TMCI 327.4K
- Earning Date
- ISD 01-01-0001
- TMCI 11-04-2025
- Dividend Yield
- ISD 9.69%
- TMCI N/A
- EPS Growth
- ISD N/A
- TMCI N/A
- EPS
- ISD N/A
- TMCI N/A
- Revenue
- ISD N/A
- TMCI $213,751,000.00
- Revenue This Year
- ISD N/A
- TMCI $10.63
- Revenue Next Year
- ISD N/A
- TMCI $9.44
- P/E Ratio
- ISD N/A
- TMCI N/A
- Revenue Growth
- ISD N/A
- TMCI 7.67
- 52 Week Low
- ISD $10.98
- TMCI $4.54
- 52 Week High
- ISD $13.17
- TMCI $10.79
- Technical
- Relative Strength Index (RSI)
- ISD 60.13
- TMCI 55.40
- Support Level
- ISD $14.44
- TMCI $6.93
- Resistance Level
- ISD $14.67
- TMCI $7.48
- Average True Range (ATR)
- ISD 0.08
- TMCI 0.32
- MACD
- ISD -0.01
- TMCI -0.06
- Stochastic Oscillator
- ISD 79.17
- TMCI 40.28
About ISD PGIM High Yield Bond Fund Inc.
PGIM High Yield Fund Inc is a diversified, closed-end management investment company, active in the financial services domain. The Fund's investment objective is to provide a high level of current income. It invests at least 80% of its investable assets in a diversified portfolio of high-yield fixed-income instruments that are rated below investment grade with varying maturities and other investments.
About TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.